太極集團(600129.SH):收到太衡公司支付的股權轉讓款共計約8.38億元
格隆匯 2 月 7日丨太極集團(600129.SH)公佈,之前披露,公司於2020年9月28日召開的第九屆董事會第二十六次會議、2020年10月16日召開的第三次臨時股東大會議,審議通過了《關於轉讓成都新衡生房地產開發有限公司部分股權的議案》。公司將持有成都新衡生房地產開發有限公司(以下簡稱:成都新衡生公司)59.42%的股權轉讓給重慶太衡企業管理諮詢有限公司(以下簡稱:太衡公司),轉讓總金額為52387.8萬元;公司全資子公司太極集團重慶涪陵製藥廠有限公司(以下簡稱:涪陵製藥廠)將持有成都新衡生公司35.58%的股權轉讓給太衡公司,轉讓總金額為31369.2萬元。
2021年2月7日,公司和涪陵制藥廠分別收到太衡公司支付的股權轉讓款52387.8萬元、31369.2萬元,共計83757萬元。截止公吿披露日,此次股權轉讓款已全部收到且成都新衡生公司已完成工商變更登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.